GB Virus C/Hepatitis G Virus Infections in Traumatologic Outpatients, Chronic Non-A-E Hepatitis and Extrahepatic Malignancies |
| |
Authors: | L Schaade CA Platzer M Kleines K Ritter |
| |
Institution: | (1) Institute for Medical Microbiology, Dept. of Virology, Technical University of the Rhineland and Westphalia Aachen, Pauwelsstr. 30, D-52074 Aachen, Germany; Phone: +49-241-8088460, Fax: +49-241-8888483, DE |
| |
Abstract: | Summary
GB virus C/hepatitis G virus (GBV-C/HGV) is a recently discovered flavivirus of still unknown pathogenic relevance. We examined
traumatologic outpatients to determine GBV-C/HGV viremia for further epidemiological studies, as blood donors hitherto used
as controls represent healthy individuals without risk factors. Anti-GBV-C/HGV antibodies were detectable in 13.2% (95% confidence
interval CI] 9.3–18.2) and GBV-C/HGV RNA was detectable in 4.5% (95% CI 2.4–8.2) of the outpatients. In chronic non-A-E hepatitis
patients GBV-C/HGV viremia was detectable at a significantly higher level of 16.1% (95% CI 6.1–:34.5), while the prevalence
of anti-GBV-C/HGV antibodies was 12.9% (95% CI 4.2–30.8). The rate of GBV-C/HGV viremia in patients with malignant diseases
(different types of tumors, blood recipients were excluded) was 12.5% (95% CI 8.4– 18.1), a significant elevation compared
to traumatologic outpatients. The seroprevalence in the tumor group was 22.1% (95% CI 16.7–28.6), also significantly elevated.
Thus, there are two messages. Firstly, testing for GBV-C/HGV may be a useful extension of the diagnostic procedure of viral
hepatitis. Secondly, common risk factors or etiologic relations of GBV-C/HGV and extrahepatic malignancies should be discussed.
Received: March 29, 1999 · Revision accepted: November 22, 1999 |
| |
Keywords: | GB virus C Hepatitis G virus Hepatitis Malignancy |
本文献已被 PubMed SpringerLink 等数据库收录! |
|